(Sharecast News) - OptiBiotix Health announced a number of commercial advancements in an update on Tuesday, disclosing its highest-ever brand-specific online sales levels in July.
The AIM-traded firm said the surge in sales could be attributed to a number of factors, including an improved website, streamlined checkout and logistics, as well as the expansion into new online sales channels.
It reported a 450% increase in online conversion rates, which it defined as the number of sales divided by the number of site visitors.
The company's products, SlimBiome Medical and Gofigure, were now listed on Amazon UK and Amazon Prime, with plans for additional listings on Amazon's international platforms in India, the UAE, and the US.
One of OptiBiotix Health's partners had meanwhile secured an international listing for products containing SlimBiome with Costco - the world's fifth-largest retailer.
While discussions for launch plans in various international territories were still ongoing, the board said the partnership was still a major step in expanding the company's global footprint.
The company also announced an initial order of £0.12m for SlimBiome from a contract manufacturer of a leading weight management and sports nutrition brand in the US.
It said the planned product launches would start in Europe this year, and expand to the US in 2024.
While specifics about the launch remained commercially sensitive, the board said further details would be released when approved by the partner.
Since April, OptiBiotix said it had also signed agreements with four new partners in Asia for the distribution of SlimBiome.
Those partners included Nasol Pharma International in Vietnam, Bonanaza Neutra in Thailand, Colorinda Chemtra in Indonesia, and NexusWise in Malaysia and Singapore.
The board said the new partners were all established specialist distributors in their respective fields, and were reporting robust interest in SlimBiome.
Finally, OptiBiotix introduced its WellBiome functional fibre and mineral blend in May, with the product receiving positive reviews on Amazon, with a 125% sales increase from July to August, and 63% repeat orders in August alone.
The company said it was planning to ramp up marketing efforts for WellBiome in the coming months, and extend its availability to other Amazon international channels.
"We are making good progress on our aims of getting existing partners returning to forecast, bringing in new partners, particularly in the US and Asia, and expanding e-commerce channels to grow online sales and reduce partner dependency," said chief executive officer Stephen O'Hara.
"This is all part of plans for each business unit - US, India, e-commerce, B2B - to reach operational profitability, at least on a monthly basis by the end of the calendar year.
"The aim for the second half of the year is to continue our focus on managing costs, growing sales and closing out ongoing discussion with a number of larger partners across first and second generation products to ensure a return on investment from our expansion in our commercial and business development team."
At 1306 BST, shares in OptiBiotix Health were up 10.49% at 30.66p.
Reporting by Josh White for Sharecast.com.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately repor...


(Sharecast News) - OptiBiotix Health reported higher annual revenue and improved margins for 2025 on Thursday, as the life sciences group said it was ...


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately repor...


(Sharecast News) - OptiBiotix Health reported higher annual revenue and improved margins for 2025 on Thursday, as the life sciences group said it was ...


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.


(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Allian...


(Alliance News) - Optibiotix Health PLC on Tuesday said it began a clinical trial to determine the effect of its Wellbiome fibre complex on cardiac su...


(Sharecast News) - OptiBiotix Health announced the start of a clinical study with Hull University Teaching Hospitals NHS Trust on Tuesday, to assess w...


SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life sciences - Non-Executive Director Alyson Levett will oversee an independent investi...